EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Telesis Bio's Enterprise Value is $55.84 Mil.
Telesis Bio's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was $-22.79 Mil. Therefore, Telesis Bio's EV-to-FCF for today is -2.45.
The historical rank and industry rank for Telesis Bio's EV-to-FCF or its related term are showing as below:
TBIO'
s EV-to-FCF Range Over the Past 10 Years
Min: -2.45 Med: 0 Max: 0
Current: -2.45
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Telesis Bio's PE Ratio (TTM) for today is calculated as:
Telesis Bio's share price for today is $0.01.
Telesis Bio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-30.780.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Telesis Bio EV-to-FCF Related Terms
Telesis Bio EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Telesis Bio's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Telesis Bio's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Telesis Bio EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Telesis Bio's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Telesis Bio's EV-to-FCF falls into.
Telesis Bio's current Enterprise Value is $55.84 Mil.
Telesis Bio's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-22.79 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Telesis Bio (TBIO) has a EV-to-FCF of -2.45 as of Jul. 11, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Telesis Bio and its competitors.
Is Telesis Bio's EV-to-FCF too high?
Telesis Bio's current EV-to-FCF is -2.45. Overall, Telesis Bio has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Telesis Bio's EV-to-FCF compare to MHTX and ABT?
Telesis Bio's EV-to-FCF of -2.45 can be compared against companies in the Medical Devices & Instruments industry. The industry median EV-to-FCF is 23.19. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.19, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Telesis Bio and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Telesis Bio's current EV-to-FCF is -2.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telesis Bio stock overvalued right now?
Telesis Bio (TBIO) has a current EV-to-FCF of -2.45. The current EV-to-FCF is -2.45. Telesis Bio's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Telesis Bio (TBIO), the current EV-to-FCF is -2.45 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Telesis Bio Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services. Its products comprise of BioXp system, BioXp kits, Benchtop reagents and BioXp biofoundry services.
12GF Score
Get the complete analysis for TBIO
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TBIO has been successfully added to your 
